Equities

Mesa Laboratories Inc

Mesa Laboratories Inc

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (USD)107.33
  • Today's Change6.47 / 6.42%
  • Shares traded41.59k
  • 1 Year change+22.15%
  • Beta0.8421
Data delayed at least 15 minutes, as of Nov 22 2024 18:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.

  • Revenue in USD (TTM)228.38m
  • Net income in USD-245.65m
  • Incorporated1982
  • Employees736.00
  • Location
    Mesa Laboratories Inc12100 W 6th AveLAKEWOOD 80228-1252United StatesUSA
  • Phone+1 (303) 987-8000
  • Fax+1 (303) 987-8989
  • Websitehttps://mesalabs.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tactile Systems Technology Inc285.05m15.45m382.51m992.0024.791.8417.271.340.6430.64311.918.660.98126.206.80287,349.805.320.90156.201.0951.4449.105.420.83093.80--0.11460.0011.2013.81259.6033.91-23.62--
Alpha Teknova Inc36.35m-31.68m388.05m210.00--4.45--10.68-0.7366-0.73660.8341.640.27703.127.44173,081.00-24.14---25.92--17.71---87.17--3.94-75.860.133---11.43--22.52------
Quanterix Corp129.33m-39.71m449.80m441.00--1.34--3.48-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Pacific Biosciences of California Inc173.15m-394.24m482.38m796.00--1.07--2.79-1.46-1.460.641.650.10341.975.78217,521.40-23.55-16.19-25.40-17.8123.8137.35-227.69-136.218.64-21.870.6634--56.2920.592.39--36.68--
Semler Scientific Inc58.94m15.91m482.70m92.0032.425.5429.168.192.052.057.5811.990.686817.209.33640,619.6018.5438.8320.3744.4188.0590.2227.0032.583.09--0.00--20.2825.9843.6932.64-0.3821--
Treace Medical Concepts Inc202.86m-61.52m494.64m516.00--4.71--2.44-0.9924-0.99243.271.680.89511.088.25393,141.50-27.15---32.22--80.61---30.33--2.98--0.3366--31.92---15.68------
SI-Bone Inc157.04m-37.40m515.42m344.00--3.11--3.28-0.9108-0.91083.823.950.68591.467.00456,497.10-16.34-27.88-18.08-30.9477.7085.03-23.82-51.097.22--0.1799--30.5220.1929.25--52.62--
Mesa Laboratories Inc228.38m-245.65m547.81m736.00--3.39--2.40-45.57-45.5742.1329.790.41862.745.96310,298.90-45.02-9.20-54.70-9.8862.4760.60-107.56-28.330.51061.350.5594---1.3215.95-27,438.28--15.260.00
Surmodics Inc126.08m-11.54m559.12m389.00--4.72--4.43-0.8145-0.81458.908.300.69222.206.03324,108.00-6.34-3.99-7.22-4.6673.8180.25-9.15-6.263.22-3.030.1991---4.914.73-651.43---12.34--
AxoGen Inc180.86m-14.31m576.51m426.00--5.80--3.19-0.3302-0.33024.162.260.93561.657.55424,544.60-7.40-13.92-8.49-15.8476.1379.74-7.91-20.282.47-1.500.3224--14.7413.6324.98--17.70--
Simulations Plus Inc70.01m9.95m602.82m243.0061.383.3038.608.610.48940.48943.459.100.3659--5.55288,119.305.206.105.556.4561.6374.0114.2218.97----0.0045.6417.5215.56-0.07033.0117.070.00
Standard Biotools Inc155.90m-170.60m603.06m534.00--1.23--3.87-0.7091-0.70910.55791.310.30542.486.01291,951.30-24.41-28.17-29.37-33.6048.5751.58-79.91-74.853.41--0.1014--8.57-1.2060.73--50.06--
Orthopediatrics Corp189.67m-28.44m641.00m247.00--1.73--3.38-1.24-1.248.2615.320.41160.45094.71767,906.90-6.17-5.40-6.78-5.9373.6875.09-15.00-15.923.68-29.230.1638--21.6220.91-1,767.25--28.29--
Iradimed Corp71.31m18.63m674.61m148.0036.468.0834.689.461.461.465.596.590.78511.426.16481,791.5020.5113.1622.4814.5877.1476.5526.1221.467.82143.270.0068.1323.0016.5934.0222.2297.77--
Varex Imaging Corp811.00m-47.70m675.26m2.30k--1.27--0.8326-1.16-1.1619.7713.020.65762.045.05352,608.70-3.83-0.1231-4.54-0.14631.6831.59-5.82-0.17481.971.400.4502---9.220.767-198.96--6.32--
Butterfly Network Inc76.22m-98.51m700.97m225.00--3.85--9.20-0.4708-0.47080.36270.85370.25430.64164.45338,755.60-32.87---38.53--29.60---129.25--2.95--0.00---10.21--20.76------
Data as of Nov 22 2024. Currency figures normalised to Mesa Laboratories Inc's reporting currency: US Dollar USD

Institutional shareholders

57.44%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 2024750.37k13.87%
Conestoga Capital Advisors LLCas of 30 Sep 2024529.11k9.78%
The Vanguard Group, Inc.as of 30 Sep 2024367.54k6.80%
Royce & Associates LPas of 30 Sep 2024347.15k6.42%
Ranger Investment Management LPas of 30 Sep 2024238.19k4.40%
SSgA Funds Management, Inc.as of 30 Sep 2024214.15k3.96%
Geneva Capital Management LLCas of 30 Sep 2024191.98k3.55%
Atlanta Capital Management Co. LLCas of 30 Sep 2024177.73k3.29%
Eagle Asset Management, Inc.as of 30 Sep 2024165.96k3.07%
Geode Capital Management LLCas of 30 Sep 2024124.76k2.31%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.